Lupin Launches Generic Sugammadex Injection in US

Lupin launches generic Sugammadex injection in US

Lupin launches generic Sugammadex injection in the US, reversing muscle relaxant effects during surgery for adults and children.

New release app for lupin foliar fungai disease control

Lupin growers can now use digital app technology as a support tool in lupin management involving foliar fungicide application decisions.

Lupin announces US FDA approval and launch of Sugammadex injection

Global pharma major Lupin announced that following approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application, the company launched Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vial in the United States. Lupin’s Sugammadex Injection is the bioequivalent to Bridion Injection of Merck, Sharp & Dohme LLC (Merck) and is indicated for the reversal of neuromus…